Ovid Therapeutics (OVID) FCF Margin Growth (1y) (2022 - 2025)
Ovid Therapeutics (OVID) FCF Margin Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | -104,210.00 |
| Jun 30, 2025 | 841,546.00 |
| Mar 31, 2025 | 337,947.00 |
| Dec 31, 2024 | -469,689.00 |
| Sep 30, 2024 | 55,296.00 |
| Jun 30, 2024 | 712,503.00 |
| Mar 31, 2024 | 708,557.00 |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 10.51 Mn |
| Mar 31, 2023 | -1.70 Mn |
| Mar 31, 2022 | -146,902.00 |